CD14 (Atibuclimab biosimilar) Antibody from ICHORBIO

Search, find, compare suppliers for anti-CD14 (Atibuclimab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD14 (Atibuclimab biosimilar)
Clonemonoclonal
Host Speciesn/a
Reactive Specieshuman
IsotypeIgG4
FormatProtein A/G purified, low endotoxin
Size100mg
Concentration5mg/ml
ApplicationsFunctional Assays. RUO
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: detects human CD14. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Atibuclimab. RUO atibuclimab is a chimeric CD14 antibody investigated for the treatment of patients with severe sepsis. It acts as a pattern recognition receptor for bacterial cell wall components in gram-positive and negative bacteria. CD14 antibody action stimulates a pro-inflammatory cytokine cascade often associated with inflammation in sepsis. Atibuclimab neutralization of this antibody results in the inhibition of TNF-a, IL-6 and IL-10, dampening systemic inflammatory responses. Atibuclimab also delays the release of sTNFR(1) and IL-1ra.
Immunogenn/a
Other Namesn/a
Gene, Accession #UniProt: P08571
Catalog #ICH5016-100mg
Price$5000
Order / More InfoCD14 (Atibuclimab biosimilar) Antibody from ICHORBIO
Product Specific Referencesn/a
ICHORBIO
ICHORBIO
ICHORBIO
Boston House, Grove Business Park
Downsview Road
Wantage OX12 9FF ENGLAND

orders@ichor.bio

https://ichor.bio

U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio


Profile of ICHORBIO

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.